Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of East Anglia Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University College London Featured PhD Programmes
University of Hong Kong Featured PhD Programmes
University College London Featured PhD Programmes
"hepatitis"×
10 miles

hepatitis PhD Projects, Programs & Scholarships

We have 8 hepatitis PhD Projects, Programs & Scholarships

  • "hepatitis" ×
  • clear all
Order by 
Showing 1 to 8 of 8
  What is the role for community pharmacy in identifying and referring people with undiagnosed hepatitis C directly to secondary care? (TWIGGMU19SF)
  Dr M Twigg
Applications accepted all year round
In order to meet the WHO directive to eliminate Hepatitis1, and in line with national priorities2, hepatitis C services in England face significant challenges to diagnose the 200,000 patients in the UK expected to have hepatitis C but not under specialist care2.
  MRC DiMeN Doctoral Training Partnership: Mechanisms of chronic liver disease associated with hepatitis C virus genotype 3 infection
  Prof M Harris, Dr F Oakley, Prof D Mann
Application Deadline: 21 January 2019
Supervisors. Professor Mark Harris, Faculty of Biological Sciences, University of Leeds and Professor Fiona Oakley, Institute of Cellular Medicine, Newcastle University.
  Dynamics of mRNA m6A methylome induced by hepatitis B virus X protein and its significance for the pathogenesis of hepatocellular carcinoma
  Dr R Rong
Applications accepted all year round
N6-methyaladenosine (m6A) has been identified as the most common internal modification in mRNA in higher eukaryotes. Recent studies suggest that m6A modification plays significant and broad roles in various physiological processes that might be linked to human diseases, such as cancers.
  Proof of concept exercise and life style verses Lifestyle and electro-stimulation of muscles to resolve NASH- the ELVIS project
  Dr J F Dillon, Prof R J Abboud
Applications accepted all year round
Non-alcoholic steato-hepatitis (NASH) affects up to 3% of the population and leads to cirrhosis, hepatocellular carcinoma and death the only treatment is weight loss and exercise.
  Precision healthcare - A novel diagnostic platform to detect liver cancer biomarkers in urine
  Dr A Salehi Reyhani, Prof S Taylor-Robinson
Application Deadline: 31 January 2019
Hepatocellular carcinoma, or liver cancer, is the 6th most common cause of cancer but the 2nd biggest cancer-killer globally. In this highly multidisciplinary project, you will help develop new methods for the detection of liver cancer at the point-of-care based on our pioneering work in miniaturised diagnostics.
  Structure and function of tetraspanin complexes involved in autophagy.
  Dr F Berditchevski
Application Deadline: 6 January 2019
This project offers the opportunity to elucidate the structure and molecular interactions of a novel tetraspanin complex involved in autophagy.
  Role of the antioxidant transcription factor Nrf2 in determining susceptibility to non-alcoholic steatohepatitis in a human liver cell model
  Prof J D Hayes, Dr J F Dillon
Applications accepted all year round
Non-alcoholic fatty liver disease (NAFLD) is a major public health concern in the UK as it is associated with obesity, and has huge economic significance.
  MRC DiMeN Doctoral Training Partnership: Rationally Designed Oncolytic Reovirus-Based Immunotherapy for Hepatocellular Carcinoma
  Dr A Samson, Prof A Whitehouse, Dr C McKimmie
Application Deadline: 21 January 2019
Background. The incidence of hepatocellular carcinoma (HCC) in the UK has increased more than four-fold since 1990, and worldwide HCC is the second biggest cause of cancer-specific mortality.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2018
All rights reserved.